Bessemer Group
ISEE

Bessemer Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bessemer Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22
Closed -$1K – 1484
2016
Q1 		$1K Buy
+22
New +$1.12K ﹤0.01% 1439
2014
Q4 		– Sell
-13,127
Closed -$511K – 1573
2014
Q3 		$511K Hold
13,127
– – ﹤0.01% 574
2014
Q2 		$555K Buy
+13,127
New +$482K ﹤0.01% 556

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bessemer Group's ISEE Position: Q2 2016 in Review

Bessemer Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2016, closing a stake of 22 shares — an estimated $1K sold.

Bessemer Group first reported a position in ISEE in Q2 2014 and held it in 3 quarters. The position peaked at $555K in Q2 2014. 182 funds tracked by Wall St. Rank hold ISEE as of Q2 2016.

  • Bessemer Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Bessemer Group sold 22 IVERIC bio, Inc. Common Stock shares in Q2 2016, an estimated $1K.
  • Bessemer Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Bessemer Group's IVERIC bio, Inc. Common Stock position peaked at $555K in Q2 2014.
  • 182 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2016.

Based on Bessemer Group's 13F filing for Q2 2016, filed 11 Aug 2016.